CHOICE OF THERAPY OF POSTOPERATIVE NEUROLOGIC COMPLICATIONS AND PREVENTIVE MAINTENANCE OF DISTRESSES OF THE HIGHEST MENTAL FUNCTIONS BY CAROTID ENDARTERECTOMY
https://doi.org/10.20538/1682-0363-2013-5-64-72
Abstract
At patients with carotid endarterectomy the relative assessment of total intravenous anaesthesia with use propofol, penetrating blockage of a cervical plexus and inhalation sevofluran is made. Markers of cerebral damage, a state of the highest mental functions were investigated. It is shown that for each kind of anaesthesia are characteristic specific level neuronal damages that affects on a state of the highest mental functions, number and character of postoperative complications. In therapy of neurologic complications and preventive maintenance cognitive distresses clinical efficacy ceracson is shown.
About the Authors
V. V. Shmelev
Altay State Medical University, Barnaul
Russian Federation
Shmelev Vadim V.
Russian Federation
Shmelev Vadim V.
M. I. Neimark
Altay State Medical University, Barnaul
Russian Federation
Neimark Mikhail I.
Russian Federation
Neimark Mikhail I.
References
1. Barnett H.J., Taylor D.W., Eliasziw M. et al. For the North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N. Engl. J. Med., 1998, vol. 339, no. 6, pp. 1415–1425.
2. Dahl T., Aasland J., Romundstad P. et al. Carotid endarterectomy: time-trends and results during a 20-year period. Int. Angiol., 2006, vol. 25, no. 3, pp. 241–248.
3. Lehot J.J., Durand P.G. Anesthesia for carotid endarterectomy. Rev. Esp. Anestesiol. Reanim., 2001, vol. 48, no. 10, pp. 499–507.
4. Levin O.S., Ahmetov V.V., Golubeva L.V. Neurology Journal, 2006, no. 4, pp. 14–19 (in Russian).
5. Pyshkina L.I., Kabanov A.A., Tekoeva A.R., Pirtshalaishvili Z.K. et al. Journal of Neuropathology and Psychiatry, 2011, vol. 111, no. 1, pp. 16–20 (in Russian).
6. Yahno N.N., Fyodorova T.S., Damulin I.V., Shcherbyuk A.N. et al. Journal of Neuropathology and Psychiatry, 2011, vol. 111, no. 3, pp. 31–37 (in Russian).
7. Babayan Ye., Zelman V.L., Polushin Yu.S. Anesthesiology and resuscitation, 2005, no. 4, pp. 4–14 (in Russian).
8. Gusev N.B. Sorosovsky educational magazine, 1998, no. 5, pp. 2–9 (in Russian).
9. Rebenko N.M., Autenshlyus A.I., Abramov V.V. et al Neuroimmunology, 2003, no. 1 (4), pp. 23–26 (in Russian).
10. Yepifantseva N.N., Borshchikova T.I., Churlyaev Yu.A. et al. The General resuscitation, 2009, no. 6, pp. 54–59 (in Russian).
11. Karyakina G.M., Nadezhdin M.V., Khinko M.A. Neurologic bulletin, 2007, vol. XXXIX, no. 1, pp. 41–44 (in Russian).
12. Chekhonin V.P, Dmitrieva T.B., Zhirkov Yu.A. Immunoassay agents. Мoscow, Medicine Publ., 2000. 415 p. (in Russian).
13. Dahlen U., Karlsson B., Nilsson O. et al. Enzymun Test for Determination of Neuron-Specifie Enolase. XXIII International Society for Oncodevelopmental Biology and Medicine. Montreal, Quebec. 1995. Рp. 113–119.
14. Brott T., Adams H.P. et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke, 1989, no. 20, pp. 964–970.
15. Kumming T.B., Berhardt J., Linden Т. Stroke, 2011, no. 4, pp. 3–19 (in Russian).
16. Dubois B., Slacevsky A., Litvan I., Pillon B. A frontal assessment battery at bedside. Neurology, 2000, no. 55, pp. 1621–1626.
17. Lezak M.D. Neuropsychological Assessment. N.Y., Oxford University Press, 1995. 349 р.
18. Fedin A.I., Rumyantseva S.A. Intensive therapy of an ischemic stroke. A management for doctors. Мoscow, Medical book Publ., 2004. 281 p. (in Russian).
19. Tazaki Y., Sakai F. et al. Treatment of acute cerebral infarction with a cholin precursor in a multicenter double-blind placebo-controlled study. Stroke, 1988, no. 19, pp. 211–216.
20. Wilterdink J. Choline precursors and acute and subacute human stroke: a meta-analysis. Stroke, 2002, no. 33, pp. 353–364.
21. Alonso de Leciñana M., Gutiérrez M., Roda J.M., Carceller F., Díez-Tejedor E. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke. J. Neurol. Sci., 2006, vol. 247, pp. 121–129.
22. Alvarez-Sabín J., Román G.C. Citicoline in vascular cognitive impairment and vascular dementia after stroke. Stroke, 2011, vol. 42 (Suppl), pp. 40–43.
23. Castellanos M., Sobrino T., Castillo J. Evolving paradigms for neuroprotection: molecular identification of ischemic penumbra. Cerebrovasc. Dis., 2006, vol. 21, no. 2, pp. 71–79.
24. Clark W.M., Warach S.J., Pettigrew L.C., Gammans R.E., Sabounjian L.A. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group. Neurology, 1997, no. 49, pp. 671–678.
25. Cohen R.A., Browndyke J.N., Moser D.J., Paul R.H., Gordon N., Sweet L. Long-term citicoline (Cytidine Diphosphate Choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes. Cerebrovasc. Dis., 2003, no. 16, pp. 199–204.
26. Davalos A., Castillo J., Alvarez-Sabin J., Secades J.J., Mercadal J., Lopez S., Cobo E., Warach S., Sherman D., Clark W.M., Lozano R. Oral citicoline in acute ischemic stroke: An individual patient data pooling analysis of clinical trials. Stroke, 2002, vol. 33, no. 12, pp. 2850–2857.
27. Hurtado O., Moro M.A., Cárdenas A., Sánchez V., Fernández-Tomé P., Leza J.C., Lorenzo P., Secades J.J., Lozano R., Dávalos A., Castillo J., Lizasoain I. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiol. Dis., 2005, no. 18, pp. 336–345.
28. Glantz St. The Medical and biologic statistics. The lane with English. Мoscow, Practice, 1998. 459 p. (in Russian)..
Review
For citations:
Shmelev V.V., Neimark M.I. CHOICE OF THERAPY OF POSTOPERATIVE NEUROLOGIC COMPLICATIONS AND PREVENTIVE MAINTENANCE OF DISTRESSES OF THE HIGHEST MENTAL FUNCTIONS BY CAROTID ENDARTERECTOMY. Bulletin of Siberian Medicine. 2013;12(5):64-72. (In Russ.) https://doi.org/10.20538/1682-0363-2013-5-64-72
Views:
684
Email this article 